bioRxiv Science⌕ Search

Biology subjects

Henry, P.-G.

Publications and source records attributed to Henry, P.-G..

2 recordsLinked to original sources

Body size interacts with the structure of the central nervous system: A multi-center in vivo neuroimaging study

Clinical research emphasizes the implementation of rigorous and reproducible study designs that rely on between-group matching or controlling for sources of biological variation such as subjects sex and age. However, corrections for body size (i.e. height and weight) are mostly lacking in clinical neuroimaging designs. This study investigates the importance of body size parameters in their relationship with spinal cord (SC) and brain magnetic resonance imaging (MRI) metrics. Data were derived from a cosmopolitan population of 267 healthy human adults (age 30.1{+/-}6.6 years old, 125 females). We show that body height correlated strongly or moderately with brain gray matter (GM) volume, cortical GM volume, total cerebellar volume, brainstem volume, and cross-sectional area (CSA) of cervical SC white matter (CSA-WM; 0.44[≤]r[≤]0.62). In comparison, age correlated weakly with cortical GM volume, precentral GM volume, and cortical thickness (-0.21[≥]r[≥]-0.27). Body weight correlated weakly with magnetization transfer ratio in the SC WM, dorsal columns, and lateral corticospinal tracts (-0.20[≥]r[≥]-0.23). Body weight further correlated weakly with the mean diffusivity derived from diffusion tensor imaging (DTI) in SC WM (r=-0.20) and dorsal columns (-0.21), but only in males. CSA-WM correlated strongly or moderately with brain volumes (0.39[≤]r[≤]0.64), and weakly with precentral gyrus thickness and DTI-based fractional anisotropy in SC dorsal columns and SC lateral corticospinal tracts (-0.22[≥]r[≥]-0.25). Linear mixture of sex and age explained 26{+/-}10% of data variance in brain volumetry and SC CSA. The amount of explained variance increased at 33{+/-}11% when body height was added into the mixture model. Age itself explained only 2{+/-}2% of such variance. In conclusion, body size is a significant biological variable. Along with sex and age, body size should therefore be included as a mandatory variable in the design of clinical neuroimaging studies examining SC and brain structure.

neuroscience↗

Longitudinal study of neurochemical, volumetric and behavioral changes in Q140 & BACHD mouse models of Huntingtons disease

Brain metabolites, detectable by magnetic resonance spectroscopy (MRS), have been examined as potential biomarkers in Huntingtons Disease (HD). In this study, the RQ140 and BACHD transgenic mouse models of HD were used to investigate the relative sensitivity of the metabolite profiling and the brain volumetry to characterize mouse HD. Magnetic resonance imaging (MRI) and 1H MRS data were acquired at 9.4 T from the transgenic mice and wild-type littermates every 3 months until death. Brain shrinkage was detectable in striatum of both mouse models at 12 months compared to littermates. In Q140 mice, increases in PCr and Gln occurred in striatum prior to cortex. Myo-inositol was significantly elevated in both regions from an early age. Lac, Ala and PE decreased in Q140 striatum. Tau increased in Q140 cortex. Metabolite changes in the BACHD cortex and striatum were minimal with a striatal decrease in Lac being most prominent, consistent with a dearth of ubiquitin and 1C2 positive aggregates detected in those regions. Binary logistical regression models generated from the Q140 metabolite data were able to predict the presence of disease in the BACHD striatal and previously published R6/2 metabolite data. Thus, neurochemical changes precede volume shrinkage and become potential biomarkers for HD mouse models Introduction

neuroscience↗